In-vitro human myogenesis model reveals novel mRNA alternative splicing isoforms

体外人类肌生成模型揭示了新的mRNA选择性剪接异构体

阅读:11
作者:Stefano Donega ,Nirad Banskota ,Jen-Hao Yang ,Martina Rossi ,Yulan Piao ,Dimitrios Tsitsipatis ,Jinshui Fan ,Supriyo De ,Charlotte A Peterson ,Mary M McDermott ,Myriam Gorospe ,Luigi Ferrucci

Abstract

Myogenesis, the process of muscle formation and regeneration, involves substantial alterations in gene expression. While alternative splicing plays a crucial role in generating proteomic diversity during development and disease, its specific contributions to human muscle differentiation have not been systematically explored. Here, we examined altered mRNA splicing during myogenesis in two human myoblast cell lines using a hybrid transcriptomic approach that combines short-read (Illumina) and long-read (Nanopore) RNA-seq analyses. We identified 13,853 new significant splicing isoforms (60,582 total), with RNAs increasing and decreasing in abundance between days 0 and 3 (3,771 and 3,649, respectively), and between days 3 and 5 (1,302 and 1,109, respectively). We identified 1,937 significant differential transcript usage events (DTUs), implicating pathways relevant for muscle regulation. These findings were validated using RT-qPCR analysis and across mouse and human models, including clinical samples from peripheral artery disease patients. Artificial Intelligence algorithms predicted 595 myogenesis-associated, high-confidence, novel protein-coding splicing isoforms. This study uncovers splicing-regulated mechanisms in muscle development and pathologies, establishing an integrative framework for studying mRNA processing, essential for future muscle biology intervention studies. Supplementary Information: The online version contains supplementary material available at 10.1038/s41598-025-16523-2. Keywords: AI-neural network; In-vitro muscle model; Myogenesis; Splicing; mRNA.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。